The first innovation grant was launched at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, 10-13 October 2012.
The creation of the innovation grant was announced during the Merck Serono satellite symposium on 10 October 2012.
The innovation grant will be awarded to support promising translational research projects to by academic researchers to improve understanding of Multiple Sclerosis for the ultimate benefit of patients. Potential research topics which could be funded through the Grant for Multiple Sclerosis Innovation include MS pathogenesis, predictive markers for treatment response and potential new treatments.
